Prescription RequiredSAROGLITAZAR 4 mg is a prescription medication used to manage non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) with metabolic dysfunction and diabetic dyslipidemia, particularly elevated triglyceride levels in people with type 2 diabetes. It belongs to the PPAR alpha/gamma agonist class and helps improve lipid metabolism, insulin sensitivity, and liver health when combined with a healthy diet and lifestyle changes.
| Generic name | SAROGLITAZAR |
| Strength | 4 mg |
| Manufacturer | Zydus |
| Package size | 45 Tablets |
| Used for | Diabetic dyslipidemia, hypertriglyceridemia, and type 2 diabetes mellitus |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Saroglitazar 4 mg works by activating PPAR-alpha and PPAR-gamma receptors. Activation of PPAR-alpha improves fat metabolism and lowers triglyceride levels, while activation of PPAR-gamma enhances insulin sensitivity and helps regulate blood glucose. Together, these effects improve lipid metabolism and support liver function.
Dr. Unnati Mehra has professional experience supporting patients with diabetes and related metabolic conditions. She follows an individualised approach to blood glucose management that considers prescribed medicines, glucose readings, nutrition, physical activity and overall health.
